KBC Group
KRTX

KBC Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

KBC Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-607
Closed -$192K – 1898
2023
Q4 		$192K Hold
607
– – ﹤0.01% 853
2023
Q3 		$103K Buy
+607
New +$114K ﹤0.01% 1003

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

KBC Group's KRTX Position: Q1 2024 in Review

KBC Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 607 shares — an estimated $192K sold.

KBC Group first reported a position in KRTX in Q3 2023 and held it in 2 quarters. The position peaked at $192K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • KBC Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • KBC Group sold 607 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $192K.
  • KBC Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • KBC Group's Karuna Therapeutics, Inc. Common Stock position peaked at $192K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on KBC Group's 13F filing for Q1 2024, filed 8 May 2024.